By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioCon Limited 

20th KM Hosur Road

Electronics City  Bangalore  560 100  India
Phone: 90-80-2808-2808 Fax: 91-80-2852-3423


SEARCH JOBS


Industry
Biotechnology






Company News
BioCon Limited (BIOCON.NS) Expands Its Strategic Partnership With CytoSorbents, Inc. For Cytosorb® To Treat SIRS And Cardiac Surgery Patients 11/3/2014 8:31:56 AM
Haselmeier GmbH Announces the Launch Of INSUPen® EZ In India By BioCon Limited (BIOCON.NS) 10/27/2014 11:20:04 AM
BioCon Limited (BIOCON.NS) Collaborates With Advaxis, Inc. For "ADXS-HPV" A Novel Cancer Immunotherapy 1/22/2014 8:37:53 AM
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/20/2014 8:08:38 AM
Mylan Inc. (MYL)-BioCon Limited (BIOCON.NS) Receive First Indian Biosimilar Regulatory Approval For Herceptin® 11/26/2013 7:27:51 AM
BioCon Limited (BIOCON.NS) Partners With CytoSorbents, Inc. to Market CytoSorb® - A "First-in-Class" Therapy for Sepsis Management 9/16/2013 7:51:28 AM
Mylan Inc. (MYL) Ties Up With BioCon Limited (BIOCON.NS) for Insulin Marketing 2/14/2013 8:37:59 AM
BioCon Limited (BIOCON.NS), Bristol-Myers Squibb Company (BMY) Sign Pact for Experimental Oral Insulin Drug 11/16/2012 7:46:49 AM
BioCon Limited (BIOCON.NS) to Sell 7.69% of Research Unit to GE Capital for $23 Million 10/31/2012 8:03:04 AM
BioCon Limited (BIOCON.NS) Close to Oral Insulin Deal With Bristol-Myers Squibb Company (BMY) 7/27/2012 7:41:31 AM
123
//-->